John M. Gill
2016
In 2016, John M. Gill earned a total compensation of $1.7M as Former President and CEO at PharmAthene, a 404% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Option Awards | $134,972 |
| Salary | $300,000 |
| Stock Awards | $1,098,978 |
| Other | $7,950 |
| Total | $1,691,900 |
Gill received $1.1M in stock awards, accounting for 65% of the total pay in 2016.
Gill also received $150K in non-equity incentive plan, $135K in option awards, $300K in salary and $8K in other compensation.
Rankings
In 2016, John M. Gill's compensation ranked 5,661st out of 14,075 executives tracked by ExecPay. In other words, Gill earned more than 59.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,661 out of 14,075 | 60th |
Division Manufacturing | 2,048 out of 5,489 | 63rd |
Major group Chemicals And Allied Products | 654 out of 1,895 | 66th |
Industry group Drugs | 490 out of 1,538 | 68th |
Industry Pharmaceutical Preparations | 389 out of 1,176 | 67th |
Source: SEC filing on September 1, 2017.
Gill's colleagues
We found four more compensation records of executives who worked with John M. Gill at PharmAthene in 2016.